EB
BIIB icon

Eastern Bank’s Biogen BIIB Stock Holding History

Eastern Bank’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$172K Hold
796
– – ﹤0.01% 410
2026
Q1 		$146K Sell
796
-60
-7% -$11.1K ﹤0.01% 410
2025
Q4 		$151K Hold
856
– – ﹤0.01% 402
2025
Q3 		$120K Hold
856
– – ﹤0.01% 437
2025
Q2 		$108K Hold
856
– – ﹤0.01% 443
2025
Q1 		$117K Hold
856
– – ﹤0.01% 428
2024
Q4 		$131K Sell
856
-68
-7% -$11.5K ﹤0.01% 420
2024
Q3 		$179K Buy
+924
New +$193K ﹤0.01% 382
2021
Q4 		– Sell
-760
Closed -$216K – 198
2021
Q3 		$216K Sell
760
-80
-10% -$26.2K 0.01% 182
2021
Q2 		$291K Hold
840
– – 0.01% 173
2021
Q1 		$235K Sell
840
-18
-2% -$4.85K 0.01% 173
2020
Q4 		$210K Hold
858
– – 0.01% 178
2020
Q3 		$244K Sell
858
-46
-5% -$12.8K 0.01% 167
2020
Q2 		$242K Sell
904
-689
-43% -$207K 0.02% 167
2020
Q1 		$504K Buy
1,593
+383
+32% +$116K 0.04% 133
2019
Q4 		$359K Hold
1,210
– – 0.02% 148
2019
Q3 		$282K Sell
1,210
-66
-5% -$15.4K 0.02% 165
2019
Q2 		$298K Sell
1,276
-55
-4% -$12.7K 0.02% 165
2019
Q1 		$314K Sell
1,331
-86
-6% -$27.1K 0.02% 166
2018
Q4 		$426K Sell
1,417
-17
-1% -$5.42K 0.03% 147
2018
Q3 		$506K Sell
1,434
-119
-8% -$41K 0.03% 143
2018
Q2 		$451K Hold
1,553
– – 0.03% 149
2018
Q1 		$424K Sell
1,553
-46
-3% -$14.3K 0.03% 156
2017
Q4 		$510K Sell
1,599
-182
-10% -$58.4K 0.03% 140
2017
Q3 		$558K Sell
1,781
-58
-3% -$17.2K 0.04% 135
2017
Q2 		$499K Sell
1,839
-215
-10% -$56.9K 0.04% 142
2017
Q1 		$561K Sell
2,054
-312
-13% -$88.2K 0.04% 137
2016
Q4 		$672K Sell
2,366
-1,381
-37% -$409K 0.05% 128
2016
Q3 		$1.17M Sell
3,747
-881
-19% -$261K 0.09% 109
2016
Q2 		$1.12M Sell
4,628
-43,978
-90% -$11.6M 0.09% 113
2016
Q1 		$12.7M Buy
48,606
+9,207
+23% +$2.43M 1.03% 42
2015
Q4 		$12.1M Buy
39,399
+143
+0.4% +$41.1K 1% 47
2015
Q3 		$11.5M Buy
39,256
+171
+0.4% +$56.5K 1% 45
2015
Q2 		$15.8M Buy
39,085
+776
+2% +$311K 1.28% 27
2015
Q1 		$16.2M Sell
38,309
-11,852
-24% -$4.67M 1.3% 25
2014
Q4 		$17M Buy
50,161
+468
+0.9% +$151K 1.35% 23
2014
Q3 		$16.4M Buy
49,693
+682
+1% +$225K 1.33% 21
2014
Q2 		$15.5M Buy
49,011
+12,655
+35% +$3.81M 1.25% 23
2014
Q1 		$11.1M Sell
36,356
-1,294
-3% -$411K 0.94% 47
2013
Q4 		$10.5M Sell
37,650
-12,408
-25% -$3.21M 0.9% 53
2013
Q3 		$12.1M Sell
50,058
-2,495
-5% -$558K 1.11% 39
2013
Q2 		$11.3M Buy
+52,553
New +$11.2M 1.05% 41

Other funds holding BIIB

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Eastern Bank's BIIB Position: Q2 2026 in Review

Eastern Bank held its Biogen (BIIB) position steady in Q2 2026 at 796 shares worth $172K. The position accounts for ﹤0.01% of the portfolio, ranked #410.

Eastern Bank first reported a position in BIIB in Q2 2013 and has held it in 42 quarters since. The position peaked at $17M in Q4 2014. 135 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Eastern Bank held 796 shares of Biogen worth $172K as of Q2 2026.
  • Eastern Bank left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of Eastern Bank's portfolio in Q2 2026, its #410 holding.
  • Eastern Bank first reported a position in Biogen in Q2 2013 and has held it in 42 quarters since.
  • Eastern Bank's Biogen position peaked at $17M in Q4 2014.
  • 135 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Eastern Bank's 13F filing for Q2 2026, filed 1 Jul 2026.